CalciMedica is trading 1.5% down in pre-market at $1.97 after closing at $2.00 on September 14, 2026; no major company-specific announcement, earnings release, regulatory decision, or analyst action explaining the decline was identified.
- Management is scheduled to present at the H.C. Wainwright Global Investment Conference on September 15.
- The previously announced appearance does not establish causation for the pre-market decline.